Mckesson (MCK) Cash from Financing Activities (2009 - 2026)
Mckesson (MCK) reported Cash from Financing Activities of -$2.8 billion for Q1 2026, up 1.23% year-over-year from -$2.8 billion in Q1 2025, and down 39.19% quarter-over-quarter from -$2.0 billion in Q4 2025.
Mckesson (MCK) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Mckesson (MCK) has 18 years of Cash from Financing Activities data on file, last reported at -$2.8 billion in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at -$2.8 billion, up 1.23% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.6 billion (down 16.8% YoY), and the FY2026 annual result was -$4.6 billion, down 16.8% from the prior year.
- Cash from Financing Activities fell to -$2.8 billion in Q1 2026 per MCK's latest filing, from -$2.0 billion in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $1.3 billion in Q4 2024 and troughed at -$2.9 billion in Q1 2025.
- A 5-year average of -$1.1 billion and a median of -$968.0 million in 2024 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities tumbled 284.72% in 2022, then soared 308.68% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at -$1.4 billion in 2022, then surged by 56.35% to -$622.0 million in 2023, then surged by 308.68% to $1.3 billion in 2024, then slumped by 256.09% to -$2.0 billion in 2025, then plunged by 39.19% to -$2.8 billion in 2026.
- Business Quant data shows MCK's Cash from Financing Activities at -$2.8 billion in Q1 2026, -$2.0 billion in Q4 2025, and -$961.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | -2.82 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 3.98 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -483.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 120.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 51.08 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -1.37 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 3.80 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 347,627.00 |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.82 Bn |
| Mar 31, 2026 | -2.82 Bn |
| Dec 31, 2025 | -2.03 Bn |
| Dec 31, 2025 | -2.03 Bn |
| Sep 30, 2025 | -961.00 Mn |
| Sep 30, 2025 | -961.00 Mn |
| Jun 30, 2025 | 1.18 Bn |
| Jun 30, 2025 | 1.18 Bn |
| Mar 31, 2025 | -2.86 Bn |
| Mar 31, 2025 | -2.86 Bn |
| Dec 31, 2024 | 1.30 Bn |
| Dec 31, 2024 | 1.30 Bn |
| Sep 30, 2024 | -1.60 Bn |
| Sep 30, 2024 | -1.60 Bn |
| Jun 30, 2024 | -809.00 Mn |
| Jun 30, 2024 | -809.00 Mn |
| Mar 31, 2024 | -968.00 Mn |
| Mar 31, 2024 | -968.00 Mn |
| Dec 31, 2023 | -622.00 Mn |
| Dec 31, 2023 | -622.00 Mn |